Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Novartis granted option for TP-10 in xeno/allotransplants; preliminary results in lung transplant

Oct. 21, 1997

Australian government awards Cortecs grant for otitis media research

Oct. 20, 1997

Advisory panel to the FDA unanimously recommends PDL's Zenapax

Oct. 20, 1997

VZV vaccines using gene product expressed during latency

Oct. 17, 1997

BioTransplant and Novartis expand xenotransplantation collaboration

Oct. 15, 1997

Magnetic protein conjugates from Behringwerke

Oct. 15, 1997

LXR files IDE with FDA for heart preservation solution

Oct. 14, 1997

Yoshitomi licenses immunosuppressant to Novartis

Oct. 13, 1997

Aviron updates vaccine clinical program

Oct. 10, 1997

Therapeutic Antibodies' CytoTAb enters clinical trials

Oct. 7, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 24, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
In the clinic for June 22, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Alkermes, Boehringer, Cambrian, F2G, Intrabio, Lexeo, Memo, Novocure,...
K2 nabs two Antengene bispecific TCEs in $2B license, option deal
BioWorld
MPM Bioimpact-spawned K2 Therapeutics Inc. inked a license deal plus option agreement, worth $980.5 million apiece, to gain ex-China rights to two of Antengene...